U.S. Congress legislation · 119th Congress
HB10369: Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
Status: In committee, September 14, 2026
To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers.
What the bill says
To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers.
From the introduced text, September 14, 2026:
A BILL To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers. SECTION 1. Short title This Act may be cited as the Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 . SECTION 2. Medicare part D pharmacy benefit manager reforms (a) In general Section 1860D-12 of the Social Security Act ( 42 U.S.C. 1395w-112 ) is amended-- (1) by adding at the end the following new subsections: (i) Requiring standardized public bidding process for pharmacy benefit managers (1) Requiring annual bid solicitation For plan years beginning on or after January 1, 2028, each contract entered into with a PDP sponsor under this part with respect to a prescription drug plan offered by such sponsor shall provide that such sponsor may only enter into a contract with a pharmacy benefit manager to provide pharmacy benefit management services on behalf of such sponsor during such plan year if such sponsor-- (A) solicits bids for such pharmacy benefit management services in accordance with the process under paragraph (2) ; and (B) includes in the submission to the Secretary under section 1860D-11(b) with respect to such plan-- (i) information sufficient to demonstrate that the sponsor accepted and considered all bids submitted by …
Sponsors
- Ryan Mackenzie (R, HD-PA-7) · primary sponsor
- Jake Auchincloss (D, HD-004)
- Rick Allen (R, HD-012)
- Lucy McBath (D, HD-006)
- Carol Miller (R, HD-WV-1)
Latest actions
- : Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- : Introduced in House
Subjects: Health
Common questions
- What is HB10369?
- HB10369 is a bill in Congress (119th Congress): Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026.
- What does HB10369 do?
- In its own words: To amend title XVIII of the Social Security Act, and the Employee Retirement Income Security Act of 1974, to create certain requirements with respect to pharmacy benefit managers.
- What is the status of HB10369?
- In committee as of September 14, 2026. Latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (September 14, 2026).
- Who sponsored HB10369?
- Ryan Mackenzie (R, HD-PA-7), with 4 co-sponsors.
- Where is the official record for HB10369?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/10369
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.